Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 7, 2008

View Archived Issues

PRX-03140 improves ADAS-Cog scores in Alzheimer's disease patients

Abbott's A-887755 under development for passive immunotherapy in Alzheimer's disease

BMS-708163, a novel gamma-secretase inhibitor, has good pharmacological profile in animals, humans

Bristol-Myers Squibb describes creation of intranasal CGRP antagonist for migraine

Genzyme reviews quarterly highlights

The Medicines Company acquires Curacyte Discovery

InteKrin completes first close of series C venture financing for USD 18.25 million

Roche profiles H1 developments

AGS-004 immunogenic in HIV patients treated with antiretroviral therapy

Pfizer reports identification of a new series of noradrenaline reuptake inhibitors

PET probe developed for imaging of immune disorders

Ariad initiates phase II clinical trial of deforolimus in advanced endometrial cancer

Cara reports positive results from phase Ia clinical trial of CR-845 for acute and chronic pain

Tolerx initiates phase III DEFEND clinical trial of otelixizumab in type 1 diabetes

Novel agents for treatment of pain, migraine, etc., patented

Inhibitex completes phase I clinical trial and initiates multiple ascending dose trial of FV-100

Achillion receives private placement financing of approximately USD 41.5 million

Recent patents reveal discovery of compounds for Alzheimer's, Parkinson's, etc.

Discovery to submit complete response to Surfaxin approvable letter by September 2008

Novel antiinfective agents disclosed in recent patents

NIAID commits USD 7.5 million of continued funding to Alnylam to develop RNAi antiviral

Biovest joins Joint U.S.-Norway Cancer Research Program

Alnylam eyes IND filing for ALN-VSP

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...